APPLIED THERAPEUTICS INC (APLT) Forecast, Price Target & Analyst Ratings
NASDAQ:APLT • US03828A1016
0.103 USD
+0 (+0.19%)
At close: Feb 2, 2026
0.1051 USD
+0 (+2.04%)
After Hours: 2/2/2026, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APPLIED THERAPEUTICS INC (APLT).
Forecast Snapshot
Consensus Price Target
$0.26
+ 147.57% Upside
Next Earnings Forecast
Release DateApr 13, 2026
PeriodQ4 / 2025
EPS Estimate-$0.12
Revenue Estimate
ChartMill Buy Consensus
48.89%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.26
Upside
+ 147.57%
From current price of $0.10 to mean target of $0.26, Based on 9 analyst forecasts
Low
$0.25
Median
$0.26
High
$0.26
Price Target Revisions
1 Month
0.00%
3 Months
-91.30%
Price Target Summary
9 analysts have analysed APLT and the average price target is 0.26 USD. This implies a price increase of 147.57% is expected in the next year compared to the current price of 0.103.
The average price target has been revised downward by 91.3% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
48.89%
APLT was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about APLT.
In the previous month the buy percentage consensus was at a similar level.
APLT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-12-23 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-12-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-12-02 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-29 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-11-29 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-19 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-09-19 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-31 | William Blair | Initiate | Outperform |
| 2024-07-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-04-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-26 | RBC Capital | Initiate | Outperform |
| 2024-03-15 | UBS | Maintains | Buy -> Buy |
| 2024-03-06 | UBS | Maintains | Buy -> Buy |
| 2024-02-22 | Leerink Partners | Initiate | Outperform |
| 2024-02-16 | Citigroup | Maintains | Buy -> Buy |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2022-08-17 | Citigroup | Maintains | Buy |
| 2022-08-16 | Barclays | Maintains | Equal-Weight |
| 2022-05-20 | Citigroup | Maintains | Buy |
| 2022-01-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 13, 2026
PeriodQ4 / 2025
EPS Estimate-$0.12
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-135.55%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
19.30%
Next Earnings Summary
APLT is expected to report earnings on 4/13/2026. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.993M | 455K -95.45% | 1.02M 124.18% | 1.275M 25.00% | 56.687M 4,346.04% | 66.572M 17.44% | 153.69M 130.86% | 269.37M 75.27% | 386.59M 43.52% | 510.74M 32.11% | 655.38M 28.32% | ||
| EBITDA YoY % growth | -82.95M 25.51% | -64.182M 22.63% | -103.874M -61.84% | -96.278M 7.31% | -94.115M 2.25% | 1.183M 101.26% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -82.95M 21.46% | -64.535M 22.20% | -104.299M -61.62% | -84.806M 18.69% | -89.604M -5.66% | -102.299M -14.17% | -87.282M 14.68% | -29.315M 66.41% | 64.885M 321.34% | 166.8M 157.07% | 276.51M 65.77% | 407.64M 47.42% | |
| Operating Margin | N/A | -645.80% | -22,922.86% | -8,314.30% | -7,027.76% | -180.46% | -131.11% | -19.07% | 24.09% | 43.15% | 54.14% | 62.20% | |
| EPS YoY % growth | -2.24 45.63% | -1.36 39.29% | -0.80 41.18% | -0.54 32.11% | -0.44 19.72% | -0.22 48.54% | -0.22 | -0.07 68.18% | 0.15 314.29% | 0.38 146.67% | 0.59 56.76% | 0.81 36.21% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -135.55% | -0.11 27.46% | -0.12 22.94% | -0.13 3.23% | -0.11 7.24% | -0.10 6.25% | -0.09 20.59% | -0.06 51.35% | -0.03 71.88% |
| Revenue Q2Q % growth | -100.00% | 15.851M | 19.431M | 25.724M | 32.191M | ||||
| EBITDA Q2Q % growth | -23.552M 27.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.112M 45.15% | -21.228M 16.83% | -22.765M 1.44% | -24.614M -46.88% | -26.863M -48.31% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.80%
EPS Next 5 Year
13.83%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
364.93%
Revenue Next 5 Year
206.95%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
26.24%
EBIT Next 5 Year
N/A
APPLIED THERAPEUTICS INC / APLT Forecast FAQ
Can you provide the average price target for APPLIED THERAPEUTICS INC stock?
9 analysts have analysed APLT and the average price target is 0.26 USD. This implies a price increase of 147.57% is expected in the next year compared to the current price of 0.103.
What is the next earnings date for APLT stock?
APPLIED THERAPEUTICS INC (APLT) will report earnings on 2026-04-13, after the market close.
What are the consensus estimates for APPLIED THERAPEUTICS INC (APLT) next earnings?
The consensus EPS estimate for the next earnings of APPLIED THERAPEUTICS INC (APLT) is -0.12 USD and the consensus revenue estimate is 0 USD.
Can you provide the consensus rating for APPLIED THERAPEUTICS INC stock?
The consensus rating for APPLIED THERAPEUTICS INC (APLT) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.